CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pelthos Therapeutics Inc.
Sign in to watch- Ticker
- PTHS
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 863335449
- Phone
- 919-908-2422
- Business address
- 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
- Former names
- Channel Therapeutics Corp, Chromocell Therapeutics Corp
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- POS EX Other Post-effective Amendment
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 10-K Other NT 10-K
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- POS EX Other Post-effective Amendment
- CERT Other Certification
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- DRS/A Other Draft Registration Statement
- DRSLTR Other Correspondence Related to Draft Registration Statement
- DRS Other Draft Registration Statement
Page 2 of 2 · 40 filings